Trade Names:
Synonyms:
Status: Approved (2010)
Entry Type: Enzyme
Molecule Category: UNKNOWN
ATC: A16AB10
UNII: 23HYE36B0I

Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME Glucocerebroside hydrolytic enzyme DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Gaucher Disease 4 D005776 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
13.87
Injury, poisoning and procedural complications
12.2
Musculoskeletal and connective tissue disorders
7.5
Respiratory, thoracic and mediastinal disorders
7.4
Nervous system disorders
7.0
Infections and infestations
6.21
Gastrointestinal disorders
6.15
Vascular disorders
6.02
Cardiac disorders
4.11
Pregnancy, puerperium and perinatal conditions
3.85
Immune system disorders
3.62
Skin and subcutaneous tissue disorders
3.42
Investigations
2.5
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
2.43
Blood and lymphatic system disorders
2.3
Psychiatric disorders
2.24
Metabolism and nutrition disorders
2.04

Cross References

Resources Reference
CAS NUMBER 884604-91-5
ChEMBL CHEMBL1201865
FDA SRS 23HYE36B0I
Guide to Pharmacology 7464